Exiqon names Harvard Medical School facility as MicroRNA Screening Center of Excellence

Posted on: Mon, 30 Nov 2009 06:55:00 EST


Symbols: EXQNF
Nov 30, 2009 (M2 EQUITYBITES via COMTEX) --
EXQNF | Quote | Chart | News | PowerRating -- Life science and diagnostics company Exiqon A/S (NASDAQ OMX
Copenhagen:EXQ) said on Monday that the Harvard Medical School
ICCB-Longwood Screening Facility (ICCB-L) has been recognised as a
MicroRNA Screening Center of Excellence.

The company said that ICCB-L is the first institution to be inducted as
an Exiqon microRNA Center of Excellence in the area of functional
studies.

ICCB-L supports investigators at Harvard Medical School and associated
hospitals and institutions for high-throughput screening of small
molecule and RNAi libraries.

The facility will be providing the Exiqon LNA microRNA Knockdown
Library as a screening tool for a new consortium of Harvard-affiliated
investigators.

Comments on this story may be sent to admin@m2.com

For full details on (EXQNF) EXQNF. (EXQNF) has Short Term PowerRatings at TradingMarkets. Details on (EXQNF) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday February 11 04:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.